Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules which activate Telomerase Reverse Transcriptase (TERT) – an enzyme which plays a major role in preventing cellular senescence. Our goal is to develop drugs which will delay the onset, and the progression of neurodegenerative diseases and specifically of ALS and improve and extend patients’ lives.In-vitro testing of AGS effec...
Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules which activate Telomerase Reverse Transcriptase (TERT) – an enzyme which plays a major role in preventing cellular senescence. Our goal is to develop drugs which will delay the onset, and the progression of neurodegenerative diseases and specifically of ALS and improve and extend patients’ lives.In-vitro testing of AGS effects on human mesenchymal stem cells derived from ALS and MS patients demonstrated increased survival and ameliorated oxidative stress.

List your booth number for exhibitions, ask us